Evidence map›Paper›PMID 38946265›Full record

ArticleJournal of chemical information and modeling2024

Caspase-Based Fusion Protein Technology: Substrate Cleavability Described by Computational Modeling and Simulation.

Jakob Liu, Andreas Fischer, Monika Cserjan-Puschmann, Nico Lingg, Chris Oostenbrink

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jakob LiuAustrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.
Andreas FischerAustrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.
Monika Cserjan-PuschmannAustrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.ORCID 0000-0002-9811-9709
Nico LinggAustrian Centre of Industrial Biotechnology, Muthgasse 18, 1190 Vienna, Austria.ORCID 0000-0002-3574-6991
Chris OostenbrinkInstitute of Molecular Modeling and Simulation, University of Natural Resources and Life Sciences, Vienna (BOKU), Muthgasse 18, 1190 Vienna, Austria.ORCID 0000-0002-4232-2556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Caspase-based fusion protein technology (CASPON) allows for universal cleavage of fusion tags from proteins of interest to reconstitute the native N-terminus. While the CASPON enzyme has been optimized to be promiscuous against a diversity of N-terminal peptides, the cleavage efficacy for larger proteins can be surprisingly low. We develop an efficient means to rationalize and predict the cleavage efficiency based on a structural representation of the intrinsically disordered N-terminal peptides and their putative interactions with the CASPON enzyme. The number of favorably interacting N-terminal conformations shows a very good agreement with the experimentally observed cleavage efficiency, in agreement with a conformational selection model. The method relies on computationally cheap molecular dynamics simulations to efficiently generate a diverse collection of N-terminal conformations, followed by a simple fitting procedure into the CASPON enzyme. It can be readily used to assess the CASPON cleavability a priori.

Indexed as

Molecular Dynamics SimulationProtein ConformationCaspasesPeptidesRecombinant Fusion ProteinsSubstrate SpecificityCaspasesPeptidesRecombinant Fusion Proteins

Identifiers

PMID38946265
PMCPMC11267566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.